Loading

Annals of Clinical Pathology

Trial in using Clostridium butyricum as Prophylactic for Salmonellosis in Broiler Chicken: Hematobiochemical, Immunological and Pathological Alterations

Research Article | Open Access

  • 1. Dept. of Clinical Pathology, Faculty of Veterinary Medicine, Zagazig University, 44511, Egypt
  • 2. MVSc of Clinical Pathology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt
+ Show More - Show Less
Corresponding Authors
Shefaa A M El-Mandrawy, Clinical Pathology Department, Faculty of Veterinary Medicine, Zagazig University, 44511, Egypt, Tel: +201061658187
Abstract

Background: Salmonellosis is a severe systemic disease of chicken, that threaten the poultry industry all over the world, thus the present study was planned to reach to accurate treatment of this serious disease, in addition to study the effect of Salmonellosis on hemato- biochemical, immunological and pathological changes in broiler chicken.

Materials and methods: 100 broiler chickens (Cobb breed), one-days-old were obtained from Dakahlia Company for poultry production and divided as following: 25 birds were clinically healthy kept as control group (I), 25 birds infected with S. Gallinarum (II), 25 birds administrated Clostri-Mix and infected with S.Gallinarum (III) and 25 birds infected with S.Gallinarum strain and treated with Ciprociel (IV). Blood and tissue samples were collected for hematobiochemical, immunological and histopathological examination.

Results: The infected broiler chickens showed sever yellowish diarrhea. In addition, decrease in body weight, gain and feed consumption with significant increase in FCR. Furthermore, hemolytic anemia with leucocytosis was observed. Biochemical studies revealed a significant decrease in serum total proteins, albumin, Ca, GSH with significant increases in serum activities of ALT and AST, P, creatinine, uric acid and MDA concentration. Immunological studies clarified significant decrease in LTR, phagocytic % and index, in addition to several histological alterations in intestine, liver and kidney of the infected birds. All these disturbances were less severe in that administer Clostridium butyricum.

Conclusion: Clostridium butyricum can increase the bird immunity against Salmonellosis, which induced sever haemolytic anemia with hepatic, renal and intestinal disorders in broiler chickens.

Citation

Nasr El-Deen NAM, El-Mandrawy SAM, Mahmoud MA (2018) Trial in using Clostridium butyricum as Prophylactic for Salmonellosis in Broiler Chicken: Hemato-biochemical, Immunological and Pathological Alterations. Ann Clin Pathol 6(1): 1130.

Keywords

• Salmonella Gallinarum; FCR; Hematology; Broiler; Ciprofloxacin

ABBREVIATIONS

LTR: Lymphocytic Transformation; P: Phosphorus; GSH: Glutathione; Cl. Butyricum: Clostridium butyricum; S. Gallinarum: Salmonella Gallinarum

INTRODUCTION

Commercial poultry is one of the fasted growing sectors of animal agriculture industry [1]. However, local chickens serve as an immediate source for meat and income when money is needed for vital family needs [2]. Poultry meat is more popular in the consumer market because of its easy digestibility and acceptance by the majority of people [3]. Poultry industry continuously grows by enhancement of new broiler strains to provide high-quality and low-cost protein requirements of the human population world wide [4].

Avian salmonellosis represents a group of acute or chronic diseases caused by one or more members of genus Salmonellae [5].

The most important pathogenic members of avian salmonellosis are the non motile Salmonella enteric subsp. enterica serovar Gallinarum and Salmonella enterica subsp. enterica Pullorum. These are host specific and represent a major concern for the poultry industry causing fowl typhoid and pullorum disease respectively [6]

Ciprofloxacin is a fluoroquinolone (FQs), with widespread using in human and animal practice [7]. It has an expanded spectrum of activity against Gram-positive and Gram-negative bacteria through inhibition of DNA gyrase. This enzyme (DNA gyrase) is very important to bacterial chromosome replication and increased antibacterial potency compared with nonfluorinated quinolines such as nalidixic acid [8].

Probiotic defined as a culture of specific living microorganisms, primarily lactobacillus species which ensures rapid and effective establishment of beneficial intestinal populations [9,10]. The using of probiotics improves the live body weight, gain and feed conversion ratio and distinctly reduce mortality [11]. Probiotic microorganisms are not pathogenic, non-toxic and most of them retain their vitality after passing the whole digestive tract. Clostridium butyricum is a butyric acid bacterium that was isolated from soil, healthy animals and human fecal matter [12]. Clostridium butyricum can produce endospores, which is a key to its ability to survive at lower pH and relatively higher bile concentrations compared with Lactobacillus and Bifidobacterium [13].

MATERIALS AND METHODS

Ethical approval

Handling and sampling were carried out using the general guidelines of the National Institutes of Health (NIH) for the Care and Use of Laboratory Animals in scientific investigations and approved by the ethics of animal use in research committee (EAURC), Zagazig University ( what is the approval number).

Preparation of bacterial strain

Twenty-four hours pure cultures of isolated S. Gallinarum biovar Gallinarum were suspended in sterile saline solution using McFarland opacity tube No. 1. The approximate cell density in this dilution was 3×108 CFU/ml (Colony Forming Units/ml).

Preparation of antibiotic

Ciprofloxacin is present under commercial name as Ciprociel. One ml Ciprociel contains 100 mg of ciprofloxacin. The recommended dose of ciprofloxacin was 5 mg/ kg body weight in drinking water for 3 successive days [14]. Therefore, each one Kg of body weight needed 0.05 ml of Ciprociel.

Animal grouping

100 broiler chickens (Cobb breed), one-days-old were obtained from Dakahlia Company –Egypt, for poultry production and selected as following: 25 birds were clinically healthy kept as control group (I), 25 birds infected with S. Gallinarum strain via crop at a dose of 0.2 ml of sterile saline containing 3×108 CFU/ ml at 4 days old group (II), 25 birds administrated Clostri-Mix as commercial name for Clostridium butyricum (2 g/L drinking water) from the age of one day old till the end of the experiment and infected with S.Gallinarum strain at 4 days old group (III) and 25 birds infected with S.Gallinarum strain at 4 days old and treated with Ciprociel (5 mg/kg b.wt) in drinking water for 3 successive days at 10 days old group (IV).

Indices for the evaluation of the growth performance

The weekly feed consumption was determined through weighting the offered feed for birds. The birds were weighted individually at 1st, 14th and 28th day old to determine the average body weight in each group. The body gain calculated by the difference in body weight throughout the periods of the experiment. The feed conversion ratio (FCR) obtained by subdivided weekly feed consumption on the weekly increase in the body weight (body gain) and this was recorded every week [15].

Sampling

Clinical signs were recorded then three blood samples were collected from wing vein from all tested groups on 2nd and 4th weeks of age. The first set of blood samples (0.5 ml from each broiler chickens) were collected in dipotassium salt of ethylenediamine tetra acetic acid (EDTA) tubes to be used for hematological variables determination. While the second blood samples (5 ml from each broiler chickens) were taken without anticoagulant in a sterile test tube for serum separation and kept for biochemical analysis. The third sample was collected in heparinized tubes for immunological studies. Postmortem findings were recorded then liver, kidney and intestine specimens were taken from freshly dead birds for histopathological examination.

Hematological studies

The erythrocytic count, hemoglobin concentration, packed cell volume, RBCs indices, total leukocytic and differential leukocytic counts were carried out by using automatic cell counter (Sysmex IV2000)

BIOCHEMICAL STUDIES

All biochemical tests were measured colorimetrically using a commercial kits of Biodiagnostic, 29th El-Tahrer Street, Dokki, Giza, Egypt and a semi-automated Photometer (5010 V5+, RIELE GmbH & Co, Berlin, Germany). Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) [16], serum total proteins and creatinine levels [17], serum albumin level [18]. Serum globulins level was calculated by subtracting the obtained albumin level from the obtained total proteins level [19]. The serum calcium level [20], the serum level of inorganic phosphorus was [21]. The uric acid levels [22]. The serum malondialdehyde (MDA) [23] and the reduced glutathione (GSH) [24].

Immunological studies

Qualitative fractionation of serum proteins for determination of serum alpha, beta and gamma globulins was carried out using polyacrylamide gel columns [25].

Histopathological examination

Specimens from liver, kidneys and intestine were collected from each group, then fixed in 10 % neutral buffered formalin for 48 hours and washed overnight under running water. The washed specimens were dehydrated by using ascending graded concentrations of ethyl alcohol starting with 75% and ending with absolute alcohol. Samples were cleared after immersing in xylol for 2 hours. The cleared samples were placed in closed jars containing 50% paraffin and incubated for 2 hours at 37o C. The samples were placed in crucible containing soft paraffin and kept in an oven at 48o C for 2 hours. The samples were blocked in hard paraffin and then cut into sections of about 5 micron thicknesses, then stained with Hematoxylin and Eosin (H&E). The sections were mounted with Canada balsam and covered with cover slide to be ready for histopathological examination [26].

Statistical analysis

Data of the current study was statistically analyzed using the computer program SPSS/PC+2001. The statistical method was one way ANOVA test, followed by Duncan’s multiple range test [27]. Data are presented as means plus or minus the standard error. The minimum level of significance was set at P < 0.05.

 

RESULTS

Clinical observations

As shown in (Figure 1), Chicks infected with S. Gallinarum group (II) showing white yellowish diarrhea, pasty vent, huddle together near the source of heat, loss of appetite, dullness and ruffled feathers.

Body Performance

Concerning the body Performance as shown in (Tables 1), chicks infected with S. Gallinarum group (II) showed a significant (P<0.05) decrease in body weight, body gain and feed consumption with significant increase in FCR in all experimental periods. Chicks that administrated Clostri-mix before and after S. Gallinarum infection group (III) showed non-significant changes in the body performance. Chicks that treated with Ciprociel after S. Gallinarum infection group (IV) showed a significant decrease in body weight, body gain and feed consumption with no significant change in FCR at the end of 2nd week of age while showed a non-significant change in all body performance parameters at the end of 4th week of age, when compared with the normal control. On the other hand, chicks of both groups (III and IV) showed a significant improvement in the body performance in all experimental periods, when compared with infected group (II).

Hematological results

Concerning the erythrogram as shown in (Tables 2), showing a significant decrease in RBCs count, Hb concentration and PCV with development of macrocytic hypochromic anemia in gps. (II, III& IV) at the end of 2nd week. Moreover, Gp. (II) showed a significant decrease in RBCs count, Hb concentration and PCV with development of macrocytic hypochromic anemia compared with normal control at the end of 4th week. In addition, the chicks of gps. (III and IV) revealed non-significant changes in erythrogram.

Concerning the leukogram at the end of 2nd week as shown in (Tables 3), it a significant leukocytosis, heterophilia and lymphopenia in gp. (II), when compared with the normal control. Gp (III) showed a significant leukocytosis and lymphocytosis in comparison with normal control. On the other hand, other cells showed non-significant changes. However, the obtained results at the end of 4th week revealed that gp. (II), showed a significant leukocytosis, heterophilia and monocytosis with non-significant changes in the counts of lymphocytes, basophils and eosinophils compared with normal control. Gp. (III) revealed a significant leukocytosis and lymphocytosis with non-significant changes in the counts of heterophils, monocytes, eosinophils and basophils. Gp. (IV) showed non-significant changes in the leukogram when compared with normal control along the experimental periods.

Biochemical changes

Liver function and protein electrophoresis: Regarding to the liver function and protein electrophoresis reports in comparison with the control group (I) as shown in (Table 4), Gps. (II, III and IV) revealed a significant increase in the serum ALT and AST activities. On the other hand, gps. (III and IV) showed a significant decrease, when compared with infected group (gp.II) at the end of 2nd week. The serum activities of AST and ALT showed non-significant changes in gps. (III and IV), when compared with normal control at the end of 4th week. Moreover, a significant decrease in serum total protein, albumin was observed in gp. (II). Gp. (III) revealed non-significant changes in serum level of total protein and albumin. On the other hand, it showed a significant increase in serum total protein and albumin, when compared with infected group. Gp. (IV) showed non-significant change in serum total protein with a significant decrease in albumin, when compared with the normal control. On the other hand, it showed a significant increase in serum total protein and albumin, when compared with infected group at the end of 2nd week but at the end of 4th week it showed non-significant changes in proteinogram when compared with normal control. On the other hand, it showed a significant increase in serum total protein and albumin, when compared with infected group. In addition, the infected chicks with S. Gallinarum (gp.II) showed a significant increase in serum globulins, alpha and gamma globulins with a significant decrease in beta globulin all experimental periods. Gp. (III) revealed a significant increase in globulins, alpha and gamma globulin in all experimental periods, when compared with normal control. Moreover a significant decrease in beta globulin was recorded. While gp. (IV), showed a significant increase in serum level of globulin, alpha and gamma globulin with a significant decrease in beta globulins when compared with the normal control at the end of 2nd week. Moreover, significant increases in alpha and gamma globulins with significant decrease in beta globulin were observed, when compared with normal control at the end of 4th week.

Kidney function tests: Regarding to Kidney function (Table 5), the serum levels of calcium and inorganic phosphorus levels demonstrated a significant decrease in gp. (II), when compared with normal control (gp.I). While gps. (III and IV) showed nonsignificant change. On the other hand, gps. (III and IV) showe a significant increase in serum calcium level, compared with infected group along the experimental periods. In addition to, a significant increase in serum levels of uric acid and creatinine in gps. (II, III and IV) when compared with the normal control. On the other hand, significant decrease in serum levels of uric acid and creatinine was recorded in gps. (III and IV), as compared with infected one. At the end of 4th week, the serum levels of uric acid and creatinine were increased significantly in gp. (II). However, gps. (III and IV) showed a significant decrease and nonsignificant changes compared with infected chicks (gp.II) and normal control respectively.

Oxidant and antioxidant: Regarding to serum malondialdehyde and reduced glutathione (Table 6) demonstrated a significant increase and decrease in MDA and GSH respectively in gps. (II, III and IV) when compared with normal control at the end of 2nd week. On the other hand, gp. (III), showed a significant decrease in MDA and increase in GSH as compared with infected group. However, at the end of 4th week the serum malondialdehyde (MDA) level was significantly increased in gps. (II and IV), with insignificant changes in gp. (III), in comparison with the normal control. On the other hand, gps. (III and IV) showed a significant decrease in MDA level in comparison with infected group (gp.II). Moreover, non-significant changes were observed in gp. (IV), when compare with normal control but, GSH revealed a significant decrease in gps. (II and IV), with nonsignificant changes in chicks administered Clostridium butyricum. On the other hand, significant increase in GSH level was recorded in gps. (III and IV), as compared with infected group (gp.II). Moreover, a non-significant change was observed in gp. (IV), when compared with normal control.

Immunological studies: During all experimental periods as shown in (Figure 2-6), the phagocytic percent and phagocytic index revealed a significant decrease in gps. (II), while gps. (III and IV) showed non-significant change, in comparison with the normal control (gp.I). A significant increase was recorded in both gps. (III and IV), as compared with infected group. The lymphocytic transformation showed non-significant change in gps. (III and IV) with significant decrease in Salmonella Gallinarum infected group, in comparison with the normal control. While gps. (III and IV) revealed a significant increase in lymphocytic transformation in comparison with infected group (gp.II).

Table 1: Body Performance of chicks in different groups (I- IV).

  2ND WEEK 4TH WEEK
  I II III IV I II III IV
B.Wt. (g) 320b ±9.6 225d ±6.5 300bc ±4.1 290c ±7.4 1020b ±12.9 700c ±25.9 980b ±15.4 990b ±13.5
B. gain (g) 194.5b ±9.9 129.9d ±6.7 186b ±3.9 164c ±7.6 410ab ±12.3 250c ±33.2 390b ±14.4 420ab ±14.8
Feed Cons. (g) 355 290 330 315 700 550 670 690
FCR 1.84b ±0.065 2.25a ±0.12 1.97b ±0.027 1.93b ±0.059 1.71b ±0.05 2.4a ±0.38 1.72b ±0.047 1.65b ±0.07
Data are expressed as the mean ± SE, n=5. Means within same row carrying different superscripts are significant different at ?0.05. 
Abbreviation: (I): Control; (II): S. Gallinarum; (III): Clostri-mix + S.Gallinarum + Clostri-mix; (IV): S. Gallinarum + Ciprociel; B.Wt: Body weight; B. 
gain: Body gain; F. Cons: Feed consumption; FCR: Feed conversion ratio.

Table 2: Erythrogram of chicks in different groups (I- IV).

  2ND WEEK 4TH WEEK
  I II III IV I II III IV
RBCs (×106 /mm3) 3.5a ±0.36 1.7c ±0.15 2.2bc±0.1 2.00bc 0.14 3.49a ±0.15 1.9b ±0.12 3.6a ±0.23 3.3a ±0.17
HB (g/dl) 11.5a ±0.3 7.3c ±0.37 8.9b ±0.45 8.5bc ±0.29 11.7a ±0.43 7.4b ±0.33 11.4a ±0.28 11.5a ±0.34
PCV (%) 31.4a ±0.61 26.6c ±0.71 29.1b ±0.46 27.6bc±0.8 31.5a ±0.37 26.2b ±0.50 31.4a ±0.69 31.2a ±0.51
MCV (fl) 3.5c ±9.3 160.7a ±11.93 133.3ab ±5.5 139.8ab ±7.2 90.9b ±3.8 140.2a ±9.8 8 88.5b ±5.7 95.8b ±6.1
MCH (pg) 34.2a ±3.5 43.8a ±3.2 40.6a ±1.82 43.5a ±3.89 33.7ab ±1.5 39.9a ±4.07 32.04b ±1.6 35.2ab ±1.8
MCHC (%) 36.6a ±1.08 27.5c ±1.56 30.5bc ±1.21 30.9bc ±1.39 37.1a ±1.14 28.3b ±1.45 36.4a ±1.36 36.9a ±1.4
Data are expressed as the mean ± SE, n=5. Means within same row carrying different superscripts are significant different at ? 0.05. 
Abbreviation: (I): Control; (II): S. Gallinarum; (III): Clostri-mix + S. Gallinarum + Clostri-mix; (IV): S. Gallinarum + Ciprociel; RBCs: Red blood cells; Hb: 
Hemoglobin; PCV: Packed cell volume; MCV: Mean corpuscular volume; MCH: Mean corpuscular hemoglobin; MCHC: Mean corpuscular hemoglobin 
concentration.

Table 3: Leukogram (×103 /µl) of chicks in different groups (I- IV).

  2ND WEEK 4TH WEEK
  I II III IV I II III IV
T.L.C 21.5b ±0.21 25.11a ±0.45 24.9 a ±0.87 21.9b ±0.42 21.63b ±0.42 24.86a ±0.47 25.29a ±0.48 21.99b ±0.33
Heterophil 5.7bc ±0.25 10.44a ±0.31 6.35b ±0.24 5.9bc ±0.18 5.6b ±0.18 8.06a ±0.48 6.3b ±0.25 5.70b ±0.20
Lymphocyte 13.5bc ±0.21 12.2d ±0.29 16.2a ±0.55 13.8b ±0.31 13.8b ±0.37 13.9b ±0.50 16.7a ±0.41 14.1b ±0.32
Monocyte 1.56a ±0.25 1.67a ±0.32 1.6a ±0.27 1.5a ±0.26 1.43b ±0.20 2.10a ±0.11 1.49b ±0.18 1.41b ±0.20
Eosinophil 0.51a ±0.01 0.53a ±0.03 0.51a ±0.01 0.52a ±0.01 0.54a ±0.01 0.53a ±0.01 0.53a ±0.01 0.52a ±0.01
Basophil 0.24a ±0.014 0.23a ±0.01 0.24a ±0.01 0.26a ±0.02 0.26a ±0.02 0.27a ±0.02 0.27a ±0.02 0.26a ±0.01
Data are expressed as the mean ± SE, n=5. Means within same row carrying different superscripts are significant different at ? 0.05. 
Abbreviation: (I): Control; (II): S. Gallinarum; (III): Clostri-mix + S. Gallinarum + Clostri-mix; (IV): S. Gallinarum + Ciprociel; TLC: Total leukocytic 
count.

Table 4: Liver function and protein electrophoresis of chicks in different groups (I- IV).

  2ND WEEK 4TH WEEK
  I II III IV I II III IV
AST (U/l) 5 0 . 2 0 d ±0.52 65.60a ±0.29 56.10c ±0.58 60.90b ±0.99 50.60b ±0.85 6 9 . 4 0 a ±1.44 54.00b ±1.89 51.00b ±1.39
ALT (U/l) 7.50e ±0.56 10.60a ±0.36 9.10bcd ±0.32 8.90cd ±0.59 7.80b ±0.45 1 1 . 4 0 a ±0.55 8.00b ±0.38 7.80b ±0.37
Total protein (g/ dl) 5 . 5 0 a b ±0.21 3.95c ±0.21 5.80ab ±0.19 5.20b ±0.20 5.60a ±0.26 3 . 9 0 b ±0.32 5.60a ±0.03 5.30a ±0.26
Albumin (g/dl) 3.50a ±0.23 1.45c ±0.20 3.00ab ±0.11 2.50b ±0.28 3.60a ±0.19 1 . 4 1 b ±0.26 3.10a ±0.11 3.40a ±0.21
Globulin (g/dl) 2.00b ±0.02 2.50a ±0.09 2.80a ±0.13 2.70a ±0.16 2.00b ±0.08 2.49a ±0.13 2.50a ±0.11 1.90b ±0.11
α- globulin (g/dl) 0.30c ±0.01 0.65ab ±0.06 0.65ab ±0.06 0.80a ±0.08 0.30b ±0.03 0.69a ±0.11 0.55a ±0.04 0.60a ±0.08
β- globulin (g/dl) 0.8b ±0.09 0.35c ±0.03 0.45c ±0.05 0.50c ±0.05 0.60b ±0.02 0.35cd ±0.02 0.45c ±0.04 0.30d ±0.02
γ- globulin (g/dl) 0.90c ±0.06 1.5ab ±0.06 1.7a ±0.08 1.4b ±0.04 1.10b ±0.11 1.45a ±0.03 1.50a ±0.07 1.00b ±0.03
Data are expressed as the mean ± SE, n=5. Means within same row carrying different superscripts are significant different at ? 0.05. 
Abbreviation: (I): Control; (II): S. Gallinarum; (III): Clostri-mix + S. Gallinarum + Clostri-mix; (IV): S. Gallinarum + Ciprociel; AST: Aspartate 
transaminase, ALT: Alanine transaminase

Table 5: Kidney function of chicks in different groups (I- IV).

  2ND WEEK 4TH WEEK
  I II III IV I II III IV
Calcium (mg/dl) 11.22ab ±0.28 8.50d ±0.35 9.98bc ±0.51 9.96bc ±0.66 11.18a ±0.52 9.30b ±0.40 10.90a ±0.43 10.96a ±0.43
Phosphorus (mg/ dl) 6.40b ±0.32 8.20a ±0.38 6.88b ±0.42 6.98b ±0.54 6.34b ±0.30 8.60a ±0.36 6.44b ±0.54 6.34b ±0.40
Uric acid (mg/dl) 4.70c ±0.16 8.02a ±0.29 5.90b ±0.41 5.77b ±0.15 4.35b ±0.23 7.25a ±0.29 4.48b ±0.20 4.3b ±0.36
Creatinine (mg/ dl) 0.92c ±0.05 1.80a ±0.18 1.40b ±0.06 1.35b ±0.05 0.96b ±0.06 1.79a ±0.20 1.14b ±0.03 1.12b ±0.06
Data are expressed as the mean ± SE, n=5. Means within same row carrying different superscripts are significant different at ? 0.05. 
Abbreviation: (I): Control; (II): S. Gallinarum; (III): Clostri-mix + S. Gallinarum + Clostri-mix; (IV): S. Gallinarum + Ciprociel.

Table 6: oxidant and antioxidant of chicks in different groups (I- IV).

  2ND WEEK 4TH WEEK
  I II III IV I II III IV
MDA (nmol/g) 4.70c ± 0.19 7.30a ±0.49 5.88b ±0.27 6.50ab ±0.16 4.8b ±0.32 6.60a ±0.53 4.92b ±0.29 5.02b ±0.29
GSH (μmol/L) 31.50a ±1.13 23.80c ±0.88 27.80b ±1.21 24.78bc ±1.40 32.20a ±1.85 25.90b ±0.81 31.85a ±1.13 31.54a ±0.61
Data are expressed as the mean ± SE, n=5. Means within same row carrying different superscripts are significant different at ? 0.05. 
Abbreviation: (I): Control; (II): S. Gallinarum; (III): Clostri-mix + S. Gallinarum + Clostri-mix; (IV): S. Gallinarum + Ciprociel; MDA: Malondialdehyde, 
GSH: Reduced glutathione.

 

DISCUSSION

Salmonella enterica serovar Gallinarum (S. Gallinarum) is the etiologic agent of Fowl Typhoid, which is a severe systemic disease of chicks and other galliform birds [28]. The nature of pathogenicity of Salmonella Gallinarum is multifactorial [29]. The Clostridium butyricum probiotic is a potential candidate since the bacterium produces butyric acid [30], which is known to have an influence on Salmonella replication [31].

The present study revealed that infected chicks by S. Gallinarum (gp II) revealed white yellowish diarrhea, pasty vent, huddle together near the source of heat, loss of appetite, dullness and ruffled feathers. These results were in agreement with Fotouh et al. [32], who observed loss of appetite, decrease in feed intake and depression, ruffled feathers, droppings, huddled together and white pasty diarrhea of in chickens experimentally infected with S. Gallinarum. Chicks administrated Cl. butyricum before and after infection with S. Gallinarum (gp III) and those infected with S. Gallinarum then treated by ciprofloxacin (gp IV) showed few depression. This indicated that ciprofloxacin and Cl. butyricum increased the survival rate of chicks challenged with S. Gallinarum, similar results were previously obtained by [33] who mentioned that administration of Cl. butyricum before infection may be promotes growth performance, immune function and reduced colonization rates of the caecum of Salmonella [34].

Regarding to body performance, chicks infected with S. Gallinarum gp. (II) Clarified a reduction in the body weight, body gain, feed consumption and an increase in the feed conversion rate in all experimental periods. The observed loss in body weight may be caused by anorexia and diarrhea [35]. Our result are in agreement with those reported by [35-40], they reported decrease in body weight, feed intake and increase in the feed conversion ratio following S. Gallinarum infection. In our opinion the loss in the body weight may be a reflection of the reduced feed intake or decreased utilization and metabolism of food stuff due to intestinal and hepatic lesion. The using of clostri-mix before and after S. Gallinarum infection as in (gp.III) showed non-significant change in body weight in all experimental periods in comparison with normal control (gp.I), but proved an improvement when compared with S. Gallinarum infected group (gp.II). These results support to the previously obtained by [41,42]. They reported that the addition of probiotics significantly improved the body weight, food consumption and food convertion ratio, compared with the E.coli infected group. Chicks administered ciprofloxacin after infection with S. Gallinarum (gp. IV), showed a significant decrease in body weight in all experimental periods compared with normal control (gp.I), but an improvement was observed when compared with infected group (gp.II). This result in agreement with Porchezhian [43], who presumed that the fluoroquinolone has influence in increasing the body weight only in infection not in healthy Regarding the erythrogram the infected group (gp.II) showed significant decrease in RBCs count, Hb concentration and packed cell volume with macrocytic hypochromic anemia that may be attributed to hemolysis of erythrocytes and release of reticulocytes to the peripheral circulation [44]. These results agreed with Chiroma et al. [45], who recorded macrocytic hypochromic anemia, Chicks of (gp.III) showed a significant decrease in RBCs count, Hb concentration and packed cell volume when compared with control group (gp.I), with macrocytic hypochromic anemia at 2nd week of age that showed an improvement in 4th week of age. This anemia may be attributed to blood loss due to hemorrhages as a result of S. Gallinarum infection [46]. These results are coordinates with those observed by [47] who found macrocytic hypochromic anemia at the 2nd week post infection. The changes of erythrogram values were less significant in this group, in comparison with group (gp.II) due to hepato-stimulatory and hepato-protective effects of the probiotic leading to production of more RBCs by bone marrow under the control of erythropoietic factors released by hepatic cells [48]. The chicks in (gp.IV), showed a significant decrease in erythrogram in the 2nd week of age with macrocytic hypochromic anemia when compared with the control (gp.I), but a significant improvement in the erythogram was observed at 4th week of age compared with S. Gallinarum infected group. This improvement of hematological parameter post treatment might be due to suppression of the drug to the microorganism that invade the host so improved absorption of essential substance for erythropiosis [49].

Concerning the leukogram, the chicks infected with S. Gallinarum, revealed a significant leukocytosis with heterophilia all over the experimental periods with significant lymphopenia till the 2nd week of age in the infected group compared with the control group. Heterophilia could be attributed to that heterophils is the mainly cell of defense in the body and it also the first line of defense which attack and engulf the foreign microorganisms as a normal response to Salmonella infection [44]. Lymphopenia may be attributed to stress resulting from S. Gallinarum infection, which stimulates the adrenal gland to secrete corticosteroid hormones, causing destruction of lymphocytes [50]. Our results in agreement with Fotouh et al. [32], who mentioned that experimental S. Gallinarum infection in chicks induced leukocytosis, heterophilia, lymphopenia. Chicks of (gp.III) showed an improvement in heterophiles toward the normal level and lymphocytosis when compared with infected group (gp.II). This lymphocytosis observed indicated the immunostimulatory effect of probiotics. These results in agreement with those reported by [51] who concluded that probiotics stimulates the immune response that increase the chickens resistance against the infection. Chicks of (gp.IV), showed a significant improvement in total leukocytes and heterophils during the experimental periods when compared with infected group (gp.II). These results were in agreement with [52] who recorded a significant decrease in total leukocytic count in infected group that treated with ciprofloxacin. In addition lymphocytosis observed only in 2nd week of age which indicates that ciprofloxacin did not show any immunostimulatory effect.

Concerning the liver enzymes, the serum AST and ALT activities in chicks of(gp.II) showed a significant increase in all experimental periods. This increase could be suggestive of hepatic affection as AST and ALT are good indicators of hepatocellular damage caused by Salmonella infection [53]. Similar results are nearly to those reported by [40]. Who recorded a significant increase in the serum AST and ALT in oral infection of S. Gallinarum. Our result confirmed with the histopathological finding which showed sever hydropic degeneration with focal replacement of necrotic hepatic tissue by mononuclear cells, Coagulative necrosis with marked vaculations of hepatocytes particularly near the necrotic area and Sever subcapsular focal hemorrhage. Chicks of (gp.III) showed an apparently significant decrease in the serum AST and ALT activities during all experimental periods compared with infected group (gp.II). This may be due to the predominant role of probiotics in attenuating the liver damage [54]. Chicks of (gp. IV), revealed an improvement in the serum AST and ALT activities toward the normal in 4th weeks of age. This could be attributed to the bactericidal effect of the drug on infection and the resulting improvement in general health conditions [55].

Concerning proteinogram and protein fraction, the S. Gallinarum infected group (gp.II) showed a significant hypoproteinemia, hypoalbuminemia and hyperglobulinemia during all experimental groups. These results were similar to those recorded by [56] who reported a significant decrease in total serum protein and albumin with a significant increase in serum levels of globulines. Moreover, the lowering of total serum protein level may be due degenerative and necrotic changes in liver caused by S. Gallinarum infection [57]. The observed hypoalbuminemia might due to liver damage caused by S. Gallinarum infection as liver is the only organ where albumin is synthesized [57]. A similar increase in globulin concentration was observed by [58] in experimental S. Gallinarum infection. Moreover, the significant increase in alpha globuins and gamma globulins, with significant decrease in beta globulin partially in agreement with Kokosharov [57] who recorded an increase in values of alpha 2 globulins and the decrease in beta and gamma globulins in experimentally infected group with S. Gallinarum. Chicks of (gp.III) showed a significant increase in the total serum protein and serum albumin during all experimental periods when compared with the infected group (gp.II). This indicates that the employment of Clostri-mix as a prophylactic could counteract the effect of S. Gallinarum infection on liver and kidneys. Using of probiotics is more effective as a prophylaxis against infection than being used as a treatment [51]. Chicks of (gp.IV) showed non significant changes in total protein, albumin and globulin as compared with control group. This improvement in protein profile may be attributed to improved state of liver in treated group as synthesis of protein, albumin and globulin occurred in liver [59].

Regarding to the kidney function, chicks that infected with S. Gallinarum infected group (gp.II) revealed a significant decrease in serum calcium level with a significant increase in serum phosphorus level all over the experimental periods, compared with normal control (gp.I). Hypocalcemia may be due to protein loss, leading to hypoalbuminemia, or by calcium reabsorption decrease [60]. Nearly similar results were reported [61] who recorded a significant decrease in calcium level in S. Gallinarum infected group. The hyperphosphatemia, in our study may be due to a decrease in the calcium level and an increase of the parathermone hormone as a result of hypocalcemia [62]. Our results are not in agreement with those reported by [61] who found that S. Gallinarum infected group show a significant decrease in phosphorus level which related to low ingestion of these nutrients, likely because these birds were not feeding properly in reason of the infection by S. Gallinarum. Chicks of gps. (III and IV), showed a significant increase in the serum calcium level in all experimental periods compared with S. Gallinarum infected group. While the serum level of phosphorus revealed a significant decrease in the same groups at the same periods. This indicate that Clostri-mix as a prophylactic or ciprofloxacin as a treatment could counteract the effect of S. Gallinarum infection.

The infected group (gp.II) showed a significant increase in serum uric acid at the 2nd week of age and a significant increase in creatinine level in all experimental periods. Similar results were in agreement with those obtained by [32] who recorded a significant increase in uric acid level after 7th and 10th DPI and significant increase in creatinine level during all the experimental periods. This may be attributed to kidney damage caused by Salmonella infection [53]. The level of creatinine and uric acid is known to reflect the state of glomerular filtration rate and kidney function. The histopathological lesion confirmed our result which showed coagulative necrosis of renal tubular epithelium and Focal replacement of renal parenchyma by mononuclear cells with pyknosis of the nuclei of some renal tubular epithelium. Administration of Cl. butyricum before and after S.Gallinarum infection (gp.III), relieved the advirse effect of S. Gallinarum infection on renal function which showed a returning in the serum uric acid and creatinine to the normal levels, when compared with infected group. Gp. (IV) showed a significant decrease in both the serum creatinine and uric acid in 2nd week of age which returned to the normal levels in the 4th week of age, compared with infected group. In our opinion, this decrease in creatinine and uric acid levels was due to the recovery of the kidneys from the lesions, produced by S. Gallinarum after ciprofloxacin treatment. These results are in accordance with those recorded by [52] who reported that administration of ciprofloxacin to E. coli infected chicks showed a significant decrease in serum uric acid and serum creatinine level.

Regarding the oxidant and antioxidant, chicks of (gp.II) showed a significant increase in MDA concentration and a significant decrease in GSH activity on 2nd, and 4th weeks of age. This due to the bacterial infection and bacterial endotoxins induces extensive damage to a variety of organs, including liver, due to the increased production of reactive oxygen intermediates and a resultant rise in lipid peroxidation. These accumulations of toxic radicals in circulation produce increase the production of antioxidant enzymes. Increasing MDA in circulation was accepted an indicator of increasing cell damage. Our results are in accordance with that reported by [63] who recorded that S. enterica caused increasing at plasma MDA levels but it caused decreasing GSH-Px activity. Chicks of gp. (III), showed a significant decrease in MDA and a significant increase in GSH when compared with infected group. This may be attributed to that Cl. butyricum could inhibit both liver and blood lipid oxidation (MDA production) in broiler chicks [64] and the potential reduction of oxidative stress of probiotics [65]. Gp. (IV) showed no significant change in MDA concentration and GSH activity when compared with infected group. This attributed to stress of ciprofloxacin and bacterial infection. Our results are in accordance with those reported by [66] who reported that infection with E. coli and treatment with ciprofloxacin produced a significant decrease in GSH activity.

Regarding the results of cell mediated immune response, gp. (II), showed a significant decrease in lymphocytic transformation rate, phagocytic percent and phagocytic index during the experimental periods. This support the previously obtained results by Sadegh et al. [67], who reported that salmonella challanging had a negative effect on the immune response of the broiler chickens throught retardation of the growth of immune organs, change in the immune profile of the immune cells produced and due to a decrease in anti-body production.

Compared with S. Gallinarum infected group, chicks administrated Cl. butyricum before and after S. Gallinarum infection (gp.III) and those which treated with ciprofloxacin (gp. IV), showed a statistical increase in lymphocytic transformation rate, phagocytic percent and phagocytic index in 2nd and 4th weeks of age. Such increase was clearer in (gp.III). Probiotics stimulate natural resistance of the organism through increasing the number of antibodies and increasing the effectiveness of macrophages, also probiotics essential for enhancement functional immune system including the presence of T and B lymphocytes in the lamina propria and the expansion and maturation of IgA [68].

Moreover, the hepatic lesions reveled sever hydropic degeneration with focal replacement of necrotic hepatic tissue by mononuclear cells, with proliferation of the von kupffer cells. In addition to, coagulative necrosis with marked vaculations of hepatocytes particularly nears the necrotic area. The intestinal lesion showed catarrhal enteritis represented by marked mononuclear cell infiltration and excess mucous secretion and sloughed some intestinal villi. These results are in harmony with the histopathological studies of the liver and intestine that reported by [69] who revealed hepatitis characterized by leukocytic infiltration at perivascular areas along with hydropic vacuolation in hepatocytes, multiple necrotic foci was noticed with Kupffer cell hyperplasia. Similar degenerative, necrotic and infiltrative lesions have been reported by [28] and [70].

CONCLUSIONS

Salmonella Gallinarum has adverse effects on blood cellular constituents, biochemical parameters, immune status, liver, kidney and intestine of infected broiler chicks. Clostridium butyricum decreases the serious effect of S. Gallinarum by increasing bird immunity when used as a prophylactic before infection.

ACKNOWLEDGMENT

Authors were greatly thankful to Dr/ Mohamed Metwally, prof. of Pathology, Faculty of Veterinary Medicine, Zagazig University for his aid in reading the histopathological alterations and Dr/ Hossam El-deen Mohamed, Lecturer of Microbiology, Faculty of Veterinary Medicine, Zagazig University for his assistance in performing the microbiological studies. The results described in this paper were part of student thesis.

REFERENCES

1. Herren R. The science of animal agriculture, 2nd ed. Delmar, Albany, New York. 2000.

2. Ekue FN, Poné KD, Mafeni MJ, Nfi AN, Njoya J. Survey of the traditional poultry production system in the Bamenda area, Cameroon. In: Characteristics and parameters of family poultry production in Africa, IAEA, Vienna, Austria. 2002; 37: 15-25.

3. Yashoda KP, Sachindra NM, Sakhare PZ, Rao DN. Microbiological quality of broiler chicken carcasses processed hygienically in a small scale poultry processing unit. J Food Quality. 2001; 24: 249-259.

4. Kemp C, Kenny M. Feeding the modern broiler for more. International Hatchery Practice. 2003; 17:11-13.

5. Lutful Kabir SM. Avian Colibacillosis and Salmonellosis: A Closer Look at Epidemiology, Pathogenesis, Diagnosis, Control and Public Health Concerns. Int J Environ Res Public Health. 2010; 7: 89-114.

6. Rosu V, Chadfield MS, Santona A, Christensen JP, Thomsen LE, Rubino S, et al. Effects of crp deletion in Salmonella enterica serotype Gallinarum. Acta Vet Scand. 2007; 49: 14.

7. Brown SA. Fluoroquinolones in animal health. J Vet Pharmacol Ther. 1996; 19: 1-4.

8. Amjad A, Naeem M, Khan K. Estimation of Selected Residual Antibiotics in Poultry Products Available in Local Markets During Summer J. Chem. Soc. Pak. 2005; 27: 637-642.

9. Crawford JS. Probiotic in animal nutrition. Proceeding of Arkansas Nutrition conference, Ankansas, USA. (1979); 45-55.

10. Fuller R. Probiotics in man and animals. J Appl Bacteriol. 1989; 66: 365-378.

11. Vegad JL. Poultry diseases. International book Distributing Companey. Printed at Nehru Road. 2004.

12. Finegold SM, Sutter VL, Mathisen GE. Normal indigenous intestinal flora. in Human Intestinal Microflora in Health and Disease. DJ. Hentiges, ed. Academic Press, New York, NY. 1983; 3-31.

13. Kong Q, He GQ , Jia JL, Zhu QL, Ruan H. Oral administration of Clostridium butyricum for modulating gastrointestinal microflora in mice. Curr Microbiol. 2011; 62: 512-517.

14. Niyogi D, Bhowmik MK. Toxicopathological changes of ciprofloxacin in broiler chickens. Indian Journal of Animal Sciences. 2003; 73: 12-15.

15. Wanger D D, Furrow R D, Bradly B D. Subchronic toxicity of growth promotors in broiler chickens. Vet. Path. (1983); 20:253-259.

16. Reitman S, Frankel S. A Colorimetric method for determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957; 28: 56-63.

17. Henry T, Richard J. Determination of serum creatinine Clin Chem: Principles and Techniques. 2nd ed. Harper and Row, New York. 1974.

18. Doumas BT, Bayso DD, Carler RJ, Peler T, schaffer R. Determination of serum albumin. Clin Chem. 1981; 27: 1632.

19. Doumas BT, Biggs HG, Arends RL, Pinto PV. Determination of serum globulin, in: Standard Methods of Clinical Chemistry. Edited by Cooper S, New York, And Academic Press. 1972; 7: 175-188.

20. Tietz NW. Determination of serum calcium fundamental of clinical chemistry. W.B. Saunders Company Philadiphia, London. 1970.

21. Goodwin J F. Determination of serum inorganic phosphorus. Clin Chem. 1970; 16: 776-780.

22. Tietz N W. Clinical Guide to Laboratory Tests. 3rd edn. Philadelphia; WB Saunders. 1995.

23. Ohkawa H, Ohishi W, Anal YK. Colorimetric method for the determination serum malondialdehyde. Biochem. 1979; 95: 351-358.

24. Beutler E, Duron O, kelly MB. Colorimetric method for the determination of reduced glutathione. J Lab Clin Med. 1963; 61: 882- 888.

25. Ornstein L. Disc electrophoresis background and theory. J Ann Acad Sci. 1964; 121: 321.

26. Bancroft J D, Stevens A, Turner D R. Theory and Practice of Histological Technique. 4th edn. Churchill Livingstone. New York, London, San Francisco, Tokoyo. 1996.

27. Duncan D B. Multiple Range and Multiple F-Test. Biometrics. 1995; 11: 142.

28. Shivaprasad H L. Fowl typhoid and pullorum disease. Rev Sci Tech. 2000; 19: 405-424.

29. Kokosharov T. Acid tolerance, bile salts and serum resistance of Salmonella gallinarum from hens. Veterinarski arhiv. 2003; 73: 277- 283.

30. Okamoto T, Sasaki M, Tsujikawa T, Fujiyama Y, Bamba T, Kusunoki M. Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats. J Gastroenterol. 2000; 35: 341-346.

31. Van Immerseel F, Boyen F, Gantois I, Timbermont L, Bohez L, Pasmans F, etal. Supplementation of coated butyric acid in the feed reduces colonization and shedding of Salmonella in poultry. Poult Sci. 2005; 84: 1851-1856.

32. Fotouh A, Gab-Allah M S, Tantawy A A, Soufy H and Nasr S M. Alterations of Blood Components in Broiler Chicks Experimentally Infected with Salmonella gallinarum. Global Veterinaria. 2014; 13: 787-793.

33. Yang C M, Cao G T, Ferket P R, Liu T T, Zhou L, Zhang L, et al. Effects of probiotic, Clostridium butyricum, on growth performance, immune function, and cecal microflora in broiler chickens. Poult Sci. 2012; 91: 2121-2129.

34. Vereecken M, Dennis Smulders D, De Gussem K. The efficacy of a Clostridium butyricum probiotic, on the colonization of the caecum of broiler chickens after infection with Salmonella enteritidis. 18th European Symposium on Poultry Nutrition. 2011; 416-418.

35. Dwivedi P, Malhotra F C. Relative pathogenicity and pathogenesis of some Salmonella serotypes in young chicks. Clinical signs and growth response. Indian J Poult Sci. 1973; 8: 241-246.

36. Tanaka Y, Tanioka S, Tanaka M, Tanigawa T, Kitamura Y, Minami S, etal. Effects of chitin and chitosan particles on BALB/c mice by oral and parenteral administration. Biomaterials. 1997; 18: 591-595.

37. Bernard S, Boivin R, Menanteau P, Lanier F. Cross protection of Salmonella abortus ovis, S. choleraesuis, S Dublin and S. gallinarum in mice induced by S. abortus ovis and S gallinarum: bacteriology and humoral response. Vet Rec. 2002; 33: 55-69.

38. Alvarez M T. Comparison of the immune responses against Salmonella enterica serovar gallinarum infection between naked neck chickens and commercial chicken line. Avian Pathol. 2003; 32: 193-203. 39.Mohamed M R K. Clinicopathological studies on the effect of marbofloxacin in quails. M. V. Sc. Thesis (Clinical pathology). Fac of Vet Med. Zagazig Univeristy. 2011.

40. Shah S N, Shayaib K, Mohammed D, Masood M, Shakoor B. Haematological and some biochemical changes in experimental fowl typhoid infection in broiler chickens. Comp Clin Pathol. 2013; 22: 83.

41. Abd-El Rahman MM. The prevention of E. coli infection in broilers by using antimicrobial feed additives. Ph. D. Thesis (Poultry and Rabbit diseases). Fac Of Vet Med Zag University. 1999.

42. Ibrahim DIM. Effect of marbofloxacin and the probiotic (nutrilac) in chickens. M.V.Sc, thesis (pharmacology). Faculty of Vet Med Zagazig University. 2005.

43. Porchezhian T. A study on the influence of immunomodulators on broiler growth and immune status. Ph.D thesis. Tamil Nadu Veterinary and Animal. Sciences University, Chennai-7, India. 2001.

44. Feldman BV, Zinki JG, Jain NC. Shalm’s Veterinary Hematology. 5th ed. Lea and Fibiger, Philadelphia, USA. 2000.

45. Chiroma MA, Adamu S, Gadzama JJ, Esievo KAN, Abdulsalam H, Sani NA, et al. Haematological changes in layers experimentally infected with S. Gallinarum. African Journal of Cellular Pathology. 2017; 8: 36- 42.

46. Nazir S, Kamil SA, Darzi MM, Mir SM, Khan AF, Amare A. Pathology of Spontaneously Occurring Salmonellosis in Commercial Broiler Chickens of Kashmir Valley. J World’s Poult Res. 2012; 2: 63-69.

47. Abd El-Baky AA, Mohamed AH, Bashandy MM, Awaad MH. Clinicopathological and Immunological Studies on Pediococcus acidilactici in Chickens. Journal of the Egyptian Veterinary Medical Association. 2014; 74: 889-910.

48. Sarma M, Sapcota D, Sarma S, Gohain A K. Herbal growth promoters on hematobiochemical constituents in broilers. Indian Vet J. 2003; 80: 946-948.

49. Abdel Aziz M. Hand book of veterinary pharmacology, 5th Ed. 2006.

50. De Groot J, Morris GW. Hypothalamic control of anterior pituitary and blood lymphocytes. J Physiol. 1950; 3: 335-346.

51. Nasr El-deen NAM. clinicopathological studies on the effect of probiotic in chickens. Ph.D (Clinical pathology), Vet. Medicine, Zagazig University, Egypt. 2005.

52. Mohamed GA. Efficacy and side effects of ciprofloxacin on E.coli infections in chickens. MVSc (Pharmacology), Vet Medicine, Zagazig University, Egypt. 2012.

53. Ahmed MA, Youssef F M, Abdel Rahman AG. Studies on the effect of thyme oil on Salmonella bacteria in broiler chicks. Assiut Veterinary Medical Journal. 2014; 60: 82-95.

54. Rishin P, Mavi SK, Bharrhan S, Shukla G, Tewari R. Protective efficacy of probiotic alone or in conjunction with a prebiotic in Salmonellainduced liver damage. FEMS Microbiol Ecol. 2009; 69: 222–230.

55. Brown SA. Fluoroquinolones in animal health. J Vet Pharm Therap. 1996; 19: 1-4.

56. Kumari D, Mishra SK, Lather D. Effect of supplementation of ashwagandha (withania somnifera) on Hemato-biochemical parameters of salmonella gallinarum infected broiler chickens. Haryana Vet. 2015; 54: 1-6.

57. Kokosharov T. Changes in the protein profile in birds with experimental acute fowl typhoid. Bulg J Vet Med. 2006; 9:189-192.

58. Mamta, Mishra SK. Biochemical alterations in broiler chickens experimentally infected with Salmonella Gallinarum following administration of Tulsi (Ocimum sanctum) leaf powder. Haryana Vet. 2007; 46: 85-88.

59. Abd El-Fatah HS. Effects of some ciprofloxacin and some growth promotants on broiler chickens challenged by Escherichia coli O78. M V Sc (Pharmacology), Vet Medicine, Zagazig University, Egypt. 2016.

60. Lewandowski AH, Campbell TW, Harrison GJ. Clinical Chemistries. In: Harrison GJ, Harrison LR. Clinical Avian Medicine, Philadelphia, W. B. Sauders. 717. 1986.

61. Garcia KO, Santana AM, Neto FOC, Simplício KMMG, Alessi AC, Júnior ÂB, et al. Experimental infection of commercial layers using a Salmonella enterica sorovar Gallinarum strain: Blood serum components and histopathological changes. Braz. J Vet Pathol. 2010; 3: 111-117.

62. Coles EH. Avian clinical pathology in “Veterinary Clinical Pathology” 4th Ed., W B Saunders Company, West Washington square, Philadelphia, Toronto. 1986.

63. Benzer F, K?l?ç A, Y?lmaz S, Eri?ir M, Timurkaan N, Erta? H B. Influence of enrofloxacin adminstrationon oxidative stress and antioxidant enzyme activities of experimentally infected broiler with salmonella enterica serovar enteriditis. Journal of New World Science Academy. 2009; 4: Article: 3B0004.

64. Liao X, Wu R, Ma G, Zhao L, Zheng Z, Zhang R. Effects of Clostridium butyricum on antioxidant properties, meat quality and fatty acid composition of broiler birds. Lipids in Health and Disease. 2015; 14: 36.

65. Truusalu K, Naaber P, Kullisaar T, Tamm H, Mikelsaar R H, Zilmer K. The influence of antibacterial and antioxidative Probiotic lactobacilli on gut mucosa in a mouse model of Salmonella infection. Microb. Ecol. Health. Dis. 2004; 16:180-187.

66. Goswami M. Studies on mechanism of antioxidant medicated protection against aminoglycoside antibiotic in Escherichia coli. J. Antimicrob. Chemother. 2010; 65: 32-37.

67. Sadeghi AA, Shawrang P, Shakorzadeh S. Immune response of Salmonella shallenged broiler chickens fed diets containing gallipro, a bacillus subtilis probiotic. Probiotics & Antimicro. Prot. 2015; 7: 24- 30.

68. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME. Probiotics and immunity. J. Gastroenterol. 2009; 44: 26-46.

69. Kumari D, Mishra SK, Lather D. Pathomicrobial studies on Salmonella Gallinarum infection in broiler chickens. Veterinary World. 2013; 6: 725-729.

70. Sujatha K, Dhanalakshmi K, Rao AS. Isolation and characterization of Salmonella Gallinarum from chicken. Indian Vet. 2003; 80: 473-474.

Received : 05 Mar 2018
Accepted : 21 Mar 2018
Published : 22 Mar 2018
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X